Undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery

Heart

Volumn 92, Issue 5, 2006, Pages 697-698

  Sambu, N ^a   Wald, D S ^a   Seddon, M ^a   Simpson, I A ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY RECANALIZATION; CORRELATION COEFFICIENT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED KINGDOM;

AGED; CORONARY ARTERY BYPASS; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 33646272428     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.069914     Document Type: Article

References (5)

1. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro heart survey programme. EUROASPIRE II study group. Eur Heart J 2001;22:554-72.
2. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003;24:1601-10.
3. Wald NJ, Law MR. A strategy to reduce cardiovascular events by more that 80%. BMJ 2003;326:1419-23.
4. Archbold RA, Zaman AG, Curzen NP, et al. Prescribing of ACE inhibitors and statins after bypass surgery: a missed opportunity for secondary prevention? Br J Cardiol 2003;10:36-43.
5. Danchin N, Grenier O, Ferrieres J, et al. Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey. Heart 2002;88:159-62.